These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31243768)

  • 1. Evaluation of Lysophospholipid Measurement in Cerebrospinal Fluid Samples using Liquid Chromatography-Tandem Mass Spectrometry.
    Morita Y; Kurano M; Sakai E; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
    Lipids; 2019 Aug; 54(8):487-500. PubMed ID: 31243768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a Measurement System for Sphingolipids in the Cerebrospinal Fluid Based on Liquid Chromatography-Tandem Mass Spectrometry, and Its Application in the Diagnosis of Carcinomatous Meningitis.
    Sakai E; Kurano M; Morita Y; Aoki J; Yatomi Y
    J Appl Lab Med; 2020 Jul; 5(4):656-670. PubMed ID: 32407524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
    Voehringer P; Fuertig R; Ferger B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():92-7. PubMed ID: 24121745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry.
    Scherer M; Schmitz G; Liebisch G
    Clin Chem; 2009 Jun; 55(6):1218-22. PubMed ID: 19325012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of 4-Methylimidazol in NMRI Mice Plasma and Cerebrospinal Fluid (CSF) by Using Liquid Chromatography Tandem Mass Spectrometry.
    Mehri F; Nazari F; Fasihi Z; Kobarfard F
    Iran J Pharm Res; 2020; 19(4):143-150. PubMed ID: 33841530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of CSF cystatin C using liquid chromatography tandem mass spectrometry.
    Matsuda C; Shiota Y; Sheikh AM; Okazaki R; Yamada K; Yano S; Minohata T; Matsumoto KI; Yamaguchi S; Nagai A
    Clin Chim Acta; 2018 Mar; 478():1-6. PubMed ID: 29246666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
    Dilly Penchala S; Alagaratnam J; Challenger E; Amara A; Else L; Winston A; Khoo S
    Biomed Chromatogr; 2020 Jan; 34(1):e4711. PubMed ID: 31629375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid.
    Sidhu R; Jiang H; Farhat NY; Carrillo-Carrasco N; Woolery M; Ottinger E; Porter FD; Schaffer JE; Ory DS; Jiang X
    J Lipid Res; 2015 Jun; 56(6):1222-33. PubMed ID: 25866316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of peptide adsorption-controlled liquid chromatography-tandem mass spectrometric (PAC-LC-MS/MS) method for simple and simultaneous quantitation of amyloid β 1-38, 1-40, 1-42 and 1-43 peptides in dog cerebrospinal fluid.
    Goda R; Kobayashi N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():137-45. PubMed ID: 22503736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
    Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
    Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of lysophosphatidylcholine measurement in the cerebrospinal fluid for differential diagnosis of neuropathic pain: Possible introduction into clinical laboratory testing.
    Kurano M; Sumitani M; Akiyama Y; Yamada M; Fujimura D; Yamaki S; Kano K; Aoki J; Hayakawa K; Takahashi T; Hirai T; Okawa A; Kume H; Ogata T; Tanaka S; Chikuda H; Yatomi Y
    Clin Chim Acta; 2023 Feb; 541():117249. PubMed ID: 36764506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.
    Delaby C; Bros P; Vialaret J; Moulinier A; Delatour V; Gabelle A; Lehmann S; Hirtz C
    Bioanalysis; 2017 Feb; 9(4):337-347. PubMed ID: 28106476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable isotope dilution ultra-high performance liquid chromatography-tandem mass spectrometry quantitative profiling of tryptophan-related neuroactive substances in human serum and cerebrospinal fluid.
    Hényková E; Vránová HP; Amakorová P; Pospíšil T; Žukauskaitė A; Vlčková M; Urbánek L; Novák O; Mareš J; Kaňovský P; Strnad M
    J Chromatogr A; 2016 Mar; 1437():145-157. PubMed ID: 26879452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary liquid chromatography and tandem mass spectrometry for the quantification of enkephalins in cerebrospinal fluid.
    Sinnaeve BA; Storme ML; Van Bocxlaer JF
    J Sep Sci; 2005 Sep; 28(14):1779-84. PubMed ID: 16224973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis.
    Hayakawa K; Kurano M; Ohya J; Oichi T; Kano K; Nishikawa M; Uranbileg B; Kuwajima K; Sumitani M; Tanaka S; Aoki J; Yatomi Y; Chikuda H
    Sci Rep; 2019 Jun; 9(1):9144. PubMed ID: 31235770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography tandem mass spectrometry assay for topiramate analysis in plasma and cerebrospinal fluid: validation and comparison with fluorescence-polarization immunoassay.
    Christensen J; Højskov CS; Poulsen JH
    Ther Drug Monit; 2002 Oct; 24(5):658-64. PubMed ID: 12352939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.
    Xue YJ; Pursley J; Arnold M
    J Pharm Biomed Anal; 2007 Apr; 43(5):1728-36. PubMed ID: 17204392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry.
    Egom EE; Fitzgerald R; Canning R; Pharithi RB; Murphy C; Maher V
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-tandem mass spectrometry method for determination of panel of neurotransmitters in cerebrospinal fluid from the rat model for tauopathy.
    Kovac A; Somikova Z; Zilka N; Novak M
    Talanta; 2014 Feb; 119():284-90. PubMed ID: 24401416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.